Total Payments
$29,354
2024 Payments
$9.33
Companies
2
Transactions
30
Medicare Patients
475
Medicare Billing
$45,740
Payment Breakdown by Category
Other$29,188 (99.4%)
Food & Beverage$146.74 (0.5%)
Travel$20.16 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,688 | 18 | 80.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,500 | 4 | 18.7% |
| Food and Beverage | $146.74 | 7 | 0.5% |
| Travel and Lodging | $20.16 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $18,345 | 21 | $0 (2021) |
| Organon Llc | $11,009 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9.33 | 1 | Organon Llc ($9.33) |
| 2023 | $2,750 | 2 | Organon LLC ($2,750) |
| 2022 | $2,750 | 2 | Organon LLC ($2,750) |
| 2021 | $10,676 | 9 | Organon LLC ($5,500) |
| 2020 | $2,419 | 3 | Merck Sharp & Dohme Corporation ($2,419) |
| 2019 | $9,692 | 11 | Merck Sharp & Dohme Corporation ($9,692) |
| 2017 | $1,058 | 2 | Merck Sharp & Dohme Corporation ($1,058) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: ETONOGESTREL | ||||||
| 07/17/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 07/17/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 08/01/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 08/01/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 09/30/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 07/19/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/01/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/01/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/01/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/01/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 03/25/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 03/25/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Travel and Lodging | Cash or cash equivalent | $20.16 | General |
| Category: WOMENS HEALTH | ||||||
| 02/25/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,031.25 | General |
| Category: WOMENS HEALTH | ||||||
| 10/07/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,031.25 | General |
| Category: WOMENS HEALTH | ||||||
| 03/11/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 02/27/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: WOMENS HEALTH | ||||||
| 10/11/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 10/11/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: WOMENS HEALTH | ||||||
| 10/09/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/20/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: WOMENS HEALTH | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 106 | 135 | $48,341 | $12,167 |
| 2022 | 4 | 103 | 163 | $51,921 | $12,852 |
| 2021 | 5 | 110 | 142 | $32,731 | $11,211 |
| 2020 | 7 | 156 | 205 | $32,013 | $9,511 |
Total Patients
475
Total Services
645
Medicare Billing
$45,740
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 68 | $21,080 | $5,641 | 26.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $16,725 | $3,374 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $6,600 | $1,652 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,936 | $1,500 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 64 | $19,392 | $5,155 | 26.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 41 | $13,899 | $3,310 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 44 | $9,460 | $2,235 | 23.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $9,170 | $2,151 | 23.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 43 | $6,536 | $2,891 | 44.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 40 | $9,200 | $2,823 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 30 | $7,050 | $2,489 | 35.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $7,005 | $2,199 | 31.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 14 | $2,940 | $809.97 | 27.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 67 | $15,075 | $4,144 | 27.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 39 | $8,970 | $3,030 | 33.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 32 | $4,768 | $1,397 | 29.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,639 | $620.40 | 37.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 11 | 15 | $600.00 | $144.51 | 24.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 13 | 13 | $429.00 | $92.92 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 24 | 28 | $532.00 | $83.28 | 15.7% |
About Dr. Robert Lambert, MD
Dr. Robert Lambert, MD is a Family Medicine healthcare provider based in Mount Pleasant, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1871754812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lambert, MD has received a total of $29,354 in payments from pharmaceutical and medical device companies, with $9.33 received in 2024. These payments were reported across 30 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,688).
As a Medicare-enrolled provider, Lambert has provided services to 475 Medicare beneficiaries, totaling 645 services with total Medicare billing of $45,740. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Mount Pleasant, NC
- Active Since 06/23/2008
- Last Updated 07/15/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871754812
Products in Payments
- NEXPLANON (Drug) $23,854
- Nexplanon (Drug) $5,500
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mount Pleasant
Donato Borrillo, M.d, M.D
Family Medicine — Payments: $13,183
Family Medicine $13,183
Dr. Jeffrey Yonce, Md, MD
Family Medicine — Payments: $10,514
Family Medicine $10,514
Alaina Payne, Md, MD
Family Medicine — Payments: $9,238
Family Medicine $9,238
Vinitha Nareddy, M.d, M.D
Family Medicine — Payments: $9,026
Family Medicine $9,026
Annu Mohan, M.d, M.D
Family Medicine — Payments: $8,226
Family Medicine $8,226
Dr. Robin Malik, M.d, M.D
Family Medicine — Payments: $6,366
Family Medicine $6,366